Detection of a gliotoxic activity in the cerebrospinal fluid from multiple sclerosis patients

Neuroscience Letters

Volumn 245, Issue 1, 1998, Pages 49-52

  Ménard, Armelle ^a   Pierig, Régine ^a   Pelletier, Jean ^b   Bensa, Patrick ^b   Belliveau, James ^a   Mandrand, Bernard ^c   Perron, Hervé ^c   Rieger, François ^a  

^a INSERM   (France)

^b TIMONE HOSPITAL   (France)

^c UNIVERSITÉ DE LYON   (France)

Author keywords

Astrocyte; Cerebrospinal fluid; Cytotoxic factor; Multiple sclerosis

Indexed keywords

RNA DIRECTED DNA POLYMERASE;

ADULT; ARTICLE; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; GLIA CELL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; TOXIN ANALYSIS;

ADULT; ANIMALS; BIOLOGICAL ASSAY; CYTOTOXICITY, IMMUNOLOGIC; CYTOTOXINS; FEMALE; HUMANS; MALE; MICE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROGLIA; RECURRENCE;

EID: 0344382070     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00171-2     Document Type: Article

References (12)

1. Carp R.I., Warner H.B., Merz G.S. Viral etiology of multiple sclerosis. Prog. Med. Virol. 24:1978;158-177.
2. Galiana E., Borde I., Marin P., Rassoulzadegan M., Cuzin F., Gros F., Rouget P., Evrard C.J. Establishment of permanent astroglial cell lines, able to differentiate in vitro, from transgenic mice carrying the polyoma virus large T gene: an alternative approach to brain cell immortalization. Neurosci. Res. 26:1990;269-277.
3. Gendelman H.E., Narayan O., Kennedy-Stoskopf S., Kennedy P.G.E., Ghotbi Z., Clements J.E., Stanley J., Pezeshkpour G. Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages. J. Virol. 58:1986;67-74.
4. Giulian D., Vaca K., Noonan C.A. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science. 250:1990;1593-1596.
5. Giulian D., Wendt E., Vaca K., Noonan C.A. The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc. Natl. Acad. Sci. USA. 90:1993;2769-2773.
6. Johnson R.T. The virology of demyelinating diseases. Ann. Neurol. 36:1994;S54-S60.
7. Ménard, A., Amouri, R., Dobránsky, T., Charriaut-Marlangue, C., Pierig, R., Cifuentes-Diaz, C., Gandhour, S., Belliveau, J., Gascan, H., Hentati, F., Lyon-Caen, O., Perron, H. and Rieger, F., A gliotoxic factor and multiple sclerosis, J. Neurol. Sci., (1997) in press.
8. Ménard A., Amouri R., Michel M., Marcel F., Brouillet A., Belliveau J., Geny C., Deforges L., Malcus-Vocanson C., Dobránsky T., Armstrong M., Lyon-Caen O., Mandrand B., Rieger F., Perron H. Gliotoxicity, reverse transcriptase activity and retroviral RNA in monocyte/macrophage culture supernatants from patients with multiple sclerosis. FEBS Lett. 413:1997;477-485.
9. Pagé B., Pagé M., Noël C. A new fluorometric assay for cytotoxicity measurements in vitro. Int. J. Oncol. 3:1993;473-476.
10. Perron, H., Garson, J.A., Bedin, F., Beseme, F., Paranhos-Baccala, G., Komurian-Pradel, F., Mallet, F., Tuke, P.W., Voisset, C., Blond, J.L., Lalande, B., Seigneurin, J.M., Mandrand, B. and the collaborative research group on MS, Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis, Proc. Natl. Acad. Sci. USA, 94 (1997) 7583-7588.
11. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtellotte W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:1983;227-231.
12. Prineas, J.W., The neuropathology of multiple sclerosis. In J.C. Koetsier (Ed.), Handbook of Clinical Neurology. Demyelinating diseases, Vol. 3 (47), Elsevier, Amsterdam, 1985, pp. 213-257.